K Richter1, P Becker, A Horton, G Dreyer. 1. Department of Medical Virology, University of Pretoria, National Health Laboratory Service, Pretoria, South Africa. karin.richter@up.ac.za
Abstract
BACKGROUND: Women accessing the public health system in Gauteng province, South Africa are largely unscreened for cervical cancer and have a high background prevalence of human immunodeficiency virus (HIV) infection. OBJECTIVES: This cross-sectional study describes the age-specific prevalence of human papillomavirus (HPV) infection and cytological abnormalities among this urban and peri-urban population. METHOD: Over the period March 2009 - September 2011, 1 524 women attending public sector primary healthcare clinics were invited to participate in a cervical cancer screening study. All participants were screened with conventional cytology and HPV testing undertaken using the HPV linear array genotyping kit (Roche Molecular Systems). RESULTS: Of 1 472 women with valid cytology results, abnormalities were detected in 17.3% (n = 255), of which 9.1% (n = 134) were high-grade squamous intraepithelial lesions, and 0.5% (n = 8) suggestive of squamous carcinoma. Of the 1,445 women with complete data, the overall and high-risk HPV DNA prevalences were 74.6% (n = 1 078) and 54.3% (n = 784), respectively. HPV type 16 and/or 18 were detected in 19.5% (n = 282) of women. Age-specific prevalence of HPV showed a plateau-shaped curve. CONCLUSIONS: The prevalences of HPV infection and abnormal cytology were much higher than previously reported in general populations in South Africa and elsewhere. Higher age-specific prevalence and similar plateau-like age-specific epidemiological curves have previously only been described in studies among HIV-positive women. These findings have implications for planning and development of cervical screening programmes in developing countries with largely unscreened populations with a high background prevalence of HIV.
BACKGROUND:Women accessing the public health system in Gauteng province, South Africa are largely unscreened for cervical cancer and have a high background prevalence of human immunodeficiency virus (HIV) infection. OBJECTIVES: This cross-sectional study describes the age-specific prevalence of human papillomavirus (HPV) infection and cytological abnormalities among this urban and peri-urban population. METHOD: Over the period March 2009 - September 2011, 1 524 women attending public sector primary healthcare clinics were invited to participate in a cervical cancer screening study. All participants were screened with conventional cytology and HPV testing undertaken using the HPV linear array genotyping kit (Roche Molecular Systems). RESULTS: Of 1 472 women with valid cytology results, abnormalities were detected in 17.3% (n = 255), of which 9.1% (n = 134) were high-grade squamous intraepithelial lesions, and 0.5% (n = 8) suggestive of squamous carcinoma. Of the 1,445 women with complete data, the overall and high-risk HPV DNA prevalences were 74.6% (n = 1 078) and 54.3% (n = 784), respectively. HPV type 16 and/or 18 were detected in 19.5% (n = 282) of women. Age-specific prevalence of HPV showed a plateau-shaped curve. CONCLUSIONS: The prevalences of HPV infection and abnormal cytology were much higher than previously reported in general populations in South Africa and elsewhere. Higher age-specific prevalence and similar plateau-like age-specific epidemiological curves have previously only been described in studies among HIV-positive women. These findings have implications for planning and development of cervical screening programmes in developing countries with largely unscreened populations with a high background prevalence of HIV.
Authors: Sumayyah Ebrahim; Xolani K Mndende; Ayesha B M Kharsany; Zizipho Z A Mbulawa; Vivek Naranbhai; Janet Frohlich; Lise Werner; Natasha Samsunder; Quarraisha Abdool Karim; Anna-Lise Williamson Journal: PLoS One Date: 2016-01-19 Impact factor: 3.240
Authors: Zizipho Z A Mbulawa; Cari van Schalkwyk; Nai-Chung Hu; Tracy L Meiring; Shaun Barnabas; Smritee Dabee; Heather Jaspan; Jean-Mari Kriek; Shameem Z Jaumdally; Etienne Muller; Linda-Gail Bekker; David A Lewis; Janan Dietrich; Glenda Gray; Jo-Ann S Passmore; Anna-Lise Williamson Journal: PLoS One Date: 2018-01-02 Impact factor: 3.240
Authors: Bayan Maraqa; Isam Lataifeh; Lian Otay; Osama Badran; Yasar Qutaiba Nouri; Ibtihal Issam; Maysa Al Hussaini Journal: Asian Pac J Cancer Prev Date: 2017-11-26
Authors: Adolf K Awua; Richard M K Adanu; Edwin K Wiredu; Edwin A Afari; Alberto Severini Journal: Infect Agent Cancer Date: 2017-05-18 Impact factor: 2.965
Authors: Emmanuel Timmy Donkoh; Francis Agyemang-Yeboah; Richard Harry Asmah; Edwin K Wiredu Journal: Medicine (Baltimore) Date: 2019-03 Impact factor: 1.889